Bank of America
CRMD icon

Bank of America’s CorMedix CRMD Stock Holding History

Bank of America’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$983K Buy
144,835
+14,266
+11% +$105K ﹤0.01% 4538
2025
Q4 		$1.52M Sell
130,569
-154,139
-54% -$1.7M ﹤0.01% 4270
2025
Q3 		$3.31M Buy
284,708
+71,905
+34% +$869K ﹤0.01% 4384
2025
Q2 		$2.62M Buy
212,803
+173,994
+448% +$1.92M ﹤0.01% 4529
2025
Q1 		$239K Sell
38,809
-21,306
-35% -$221K ﹤0.01% 6079
2024
Q4 		$487K Buy
60,115
+1,124
+2% +$11.2K ﹤0.01% 5554
2024
Q3 		$477K Buy
58,991
+21,014
+55% +$114K ﹤0.01% 5514
2024
Q2 		$164K Buy
37,977
+9,820
+35% +$49.9K ﹤0.01% 5994
2024
Q1 		$119K Sell
28,157
-34,523
-55% -$120K ﹤0.01% 6159
2023
Q4 		$236K Buy
62,680
+30,360
+94% +$104K ﹤0.01% 5985
2023
Q3 		$120K Buy
32,320
+7,753
+32% +$30.8K ﹤0.01% 6172
2023
Q2 		$97.4K Buy
24,567
+4,128
+20% +$20.4K ﹤0.01% 6215
2023
Q1 		$84.6K Buy
20,439
+4,830
+31% +$19.8K ﹤0.01% 6310
2022
Q4 		$65.9K Buy
15,609
+8,232
+112% +$29.1K ﹤0.01% 6395
2022
Q3 		$21K Buy
7,377
+101
+1% +$420 ﹤0.01% 7006
2022
Q2 		$29K Sell
7,276
-19,831
-73% -$73.7K ﹤0.01% 7052
2022
Q1 		$148K Sell
27,107
-28,725
-51% -$132K ﹤0.01% 6639
2021
Q4 		$255K Buy
55,832
+17,345
+45% +$86.1K ﹤0.01% 6345
2021
Q3 		$180K Buy
38,487
+3,965
+11% +$23.1K ﹤0.01% 6371
2021
Q2 		$237K Sell
34,522
-32,547
-49% -$259K ﹤0.01% 5982
2021
Q1 		$670K Buy
67,069
+35,732
+114% +$376K ﹤0.01% 5149
2020
Q4 		$233K Buy
31,337
+4,697
+18% +$31.9K ﹤0.01% 5501
2020
Q3 		$161K Sell
26,640
-1,275
-5% -$6.4K ﹤0.01% 5415
2020
Q2 		$177K Buy
27,915
+11,914
+74% +$55.2K ﹤0.01% 5327
2020
Q1 		$57K Buy
16,001
+6,840
+75% +$38.6K ﹤0.01% 5814
2019
Q4 		$67K Sell
9,161
-593
-6% -$3.62K ﹤0.01% 6162
2019
Q3 		$63K Buy
9,754
+4,671
+92% +$39.2K ﹤0.01% 6230
2019
Q2 		$46K Sell
5,083
-37,798
-88% -$297K ﹤0.01% 6332
2019
Q1 		$405K Buy
42,881
+41,856
+4,084% +$377K ﹤0.01% 5144
2018
Q4 		$7K Buy
1,025
+25
+3% +$167 ﹤0.01% 6697
2018
Q3 		$5K Buy
1,000
+600
+150% +$1.48K ﹤0.01% 6818
2018
Q2 		$0 Hold
400
– – ﹤0.01% 7109
2018
Q1 		$0 Sell
400
-6,000
-94% -$12K ﹤0.01% 7132
2017
Q4 		$16K Buy
6,400
+1,000
+19% +$2.87K ﹤0.01% 6485
2017
Q3 		$14K Hold
5,400
– – ﹤0.01% 6417
2017
Q2 		$12K Buy
5,400
+2,106
+64% +$7.2K ﹤0.01% 6373
2017
Q1 		$27K Buy
3,294
+2,894
+724% +$27.6K ﹤0.01% 6191
2016
Q4 		$3K Sell
400
-45
-10% -$455 ﹤0.01% 6786
2016
Q3 		$6K Sell
445
-1,927
-81% -$18K ﹤0.01% 6543
2016
Q2 		$24K Buy
+2,372
New +$36.1K ﹤0.01% 6161
2016
Q1 		– Sell
-166
Closed -$2K – 7050
2015
Q4 		$2K Sell
166
-668
-80% -$7.69K ﹤0.01% 7087
2015
Q3 		$8K Sell
834
-97
-10% -$1.5K ﹤0.01% 6629
2015
Q2 		$18K Sell
931
-4,829
-84% -$166K ﹤0.01% 6362
2015
Q1 		$283K Buy
5,760
+4,760
+476% +$113K ﹤0.01% 4700
2014
Q4 		$10K Buy
+1,000
New +$7.96K ﹤0.01% 7050
2014
Q2 		– Sell
-220
Closed -$3K – 8034
2014
Q1 		$3K Buy
220
+167
+315% +$1.96K ﹤0.01% 7454
2013
Q4 		$0 Buy
+53
New +$231 ﹤0.01% 7915
2013
Q3 		– Sell
-19
Closed – – 7887
2013
Q2 		$0 Buy
+19
New +$69 ﹤0.01% 7691

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America's CRMD Position: Q1 2026 in Review

Bank of America increased its CorMedix (CRMD) stake by 11% in Q1 2026, buying an estimated $105K and bringing the position to 144,835 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #4538.

Bank of America first reported a position in CRMD in Q2 2013 and has held it in 48 quarters since. The position peaked at $3.31M in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Bank of America held 144,835 shares of CorMedix worth $983K as of Q1 2026.
  • Bank of America bought 14,266 CorMedix shares in Q1 2026, an estimated $105K.
  • CorMedix made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4538 holding.
  • Bank of America first reported a position in CorMedix in Q2 2013 and has held it in 48 quarters since.
  • Bank of America's CorMedix position peaked at $3.31M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.